Aphria Inc. announced the promotion of Jakob Ripshtein to President of the Company, effective today. As President, Ripshtein will continue to report to the Chief Executive Officer and have responsibility for the Company’s operating units worldwide.

Mr. Ripshtein’s decades of experience in regulated industries has helped move the Company forward, with a focus on growth and innovation. Since joining Aphria as Chief Commercial Officer in May, Jakob has played a critical role in the Company’s strategic planning in commercial business, sales and marketing.

“Jakob’s leadership has been instrumental in guiding Aphria through several acquisitions and investments, product innovation, and the Company’s global expansion into Latin America and Europe,” said Vic Neufeld, Chief Executive Officer of Aphria. “As we enter this new era of legalization, both medicinal and adult-use in Canada and around the world, Jakob’s strategic thinking, strong business acumen and relationship building skills will continue to be a tremendous asset in this new role. Further, his experience in the United States will greatly assist the Aphria team as we continue to evaluate various opportunities.”

“We’re fortunate that Aphria has strong bench strength when it comes to leadership, and we will continue to add to it. Our team will ensure each market has strong operations and that the Company continues to produce quality and innovative products,” added Mr. Neufeld.

Prior to joining Aphria, Mr. Ripshtein served as Chief Financial Officer of Diageo North America. In his 10 years with Diageo, he also served as President of Diageo Canada and held a variety of Finance and Commercial roles in Canada, the United States and England. While serving as President of Diageo Canada, Mr. Ripshtein managed Diageo Canada’s overall operations and resources and strove to continually improve Diageo’s relationships with its critical stakeholders – brokers, Provincial Liquor Regulators, and Provincial and Federal authorities. Prior to Diageo, he oversaw business, sales and tax functions in the Canadian spirits, pharmaceutical and financial sectors.